Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 1991Journal of Clinical OncologyOpen Access

Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group.

View Full Paper
Ask AI
Bookmark
Share

Authors

JWJ. WilsRadboud University NijmegenHKHerman O. KleinUniversity of CologneDWD. J. Th. WagenerRadboud University Nijmegen

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wils et al. (1991) studied this question.

synapsesocial.com/papers/6a7b294f2eb3c7e469f43fb0https://doi.org/10.1200/jco.1991.9.5.827
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Enhanced 5-Fluorouracil Nucleotide Formation After Methotrexate Administration: Explanation for Drug Synergism1979 · 249 citations
  2. 2Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer.1989 · 303 citations
  3. 3An EORTC Gastrointestinal Group evaluation of the combination of sequential methotrexate and 5-fluorouracil, combined with adriamycin in advanced measurable gastric cancer.1986 · 114 citations
  4. 4Current status of chemotherapy for advanced pancreatic and gastric cancer.1985 · 91 citations
  5. 5A phase II study of combined 5-fluorouracil, doxorubicin, and cisplatin in the treatment of advanced upper gastrointestinal adenocarcinomas.1986 · 133 citations